Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1957 1
1963 1
1965 1
1966 1
1967 1
1968 1
1969 2
1970 1
1973 3
1974 2
1975 4
1976 4
1977 10
1978 2
1979 5
1980 6
1981 6
1982 3
1983 5
1984 2
1985 2
1987 5
1988 3
1989 1
1990 6
1991 4
1992 4
1993 11
1994 9
1995 11
1996 9
1997 11
1998 13
1999 10
2000 6
2001 8
2002 6
2003 4
2004 4
2005 11
2006 6
2007 4
2008 4
2009 5
2010 5
2011 3
2012 7
2013 4
2014 4
2015 8
2016 8
2017 10
2018 5
2019 5
2020 10
2021 12
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

290 results
Results by year
Filters applied: . Clear all
Page 1
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, Dantonio A, Di L, Eng H, Ferre R, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lee JC, Lee J, Liu W, Mason SW, Noell S, Novak JJ, Obach RS, Ogilvie K, Patel NC, Pettersson M, Rai DK, Reese MR, Sammons MF, Sathish JG, Singh RSP, Steppan CM, Stewart AE, Tuttle JB, Updyke L, Verhoest PR, Wei L, Yang Q, Zhu Y. Owen DR, et al. Among authors: tuttle jb. Science. 2021 Dec 24;374(6575):1586-1593. doi: 10.1126/science.abl4784. Epub 2021 Nov 2. Science. 2021. PMID: 34726479
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM; BLAZE-2 Investigators. Cohen MS, et al. Among authors: tuttle jl. JAMA. 2021 Jul 6;326(1):46-55. doi: 10.1001/jama.2021.8828. JAMA. 2021. PMID: 34081073 Free PMC article. Clinical Trial.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Sandborn WJ, Ferrante M, Bhandari BR, Berliba E, Feagan BG, Hibi T, Tuttle JL, Klekotka P, Friedrich S, Durante M, Morgan-Cox M, Laskowski J, Schmitz J, D'Haens GR. Sandborn WJ, et al. Among authors: tuttle jl. Gastroenterology. 2020 Feb;158(3):537-549.e10. doi: 10.1053/j.gastro.2019.08.043. Epub 2019 Sep 4. Gastroenterology. 2020. PMID: 31493397 Free article. Clinical Trial.
Hemophilic Arthropathy.
Nacca CR, Harris AP, Tuttle JR. Nacca CR, et al. Among authors: tuttle jr. Orthopedics. 2017 Nov 1;40(6):e940-e946. doi: 10.3928/01477447-20170619-05. Epub 2017 Jun 30. Orthopedics. 2017. PMID: 28662249 Review.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
Sands BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, Fischer M, Jairath V, Hirai F, D'Haens G, Belin RM, Miller D, Gomez-Valderas E, Naegeli AN, Tuttle JL, Pollack PF, Sandborn WJ. Sands BE, et al. Among authors: tuttle jl. Gastroenterology. 2022 Feb;162(2):495-508. doi: 10.1053/j.gastro.2021.10.050. Epub 2021 Nov 5. Gastroenterology. 2022. PMID: 34748774 Clinical Trial.
Strategies to Reduce Errors Associated with 2-Component Vaccines.
Samad F, Burton SJ, Kwan D, Porter N, Smetzer J, Cohen MR, Tuttle J, Baker D, Doherty DE. Samad F, et al. Among authors: tuttle j. Pharmaceut Med. 2021 Jan;35(1):1-9. doi: 10.1007/s40290-020-00362-9. Epub 2020 Nov 5. Pharmaceut Med. 2021. PMID: 33151497 Free PMC article.
290 results